Retail giant Walmart halts sales of Zantac and related drugs

Retail giant Walmart halts sales of Zantac and related drugs
In this Sept. 30, 2019, file photo a box of Maximum Strength Zantac tablets is shown at a pharmacy in Miami Beach, Fla. Walmart has become the latest store to halt sales of the popular heartburn treatment Zantac after health regulators warned about a potentially dangerous contaminant in the drug. (AP Photo/Wilfredo Lee, File)

Walmart has become the latest store to halt sales of the popular heartburn treatment Zantac after health regulators warned about a potentially dangerous contaminant in the drug.

The 's largest retailer said Wednesday that it suspended sales of all drugs sold over the counter, or without a prescription, that include Zantac's active ingredient, ranitidine. Aside from Zantac, that includes Equate and Member's Mark brands.

The U.S. Food and Drug Administration said last month it detected low levels of a probable cancer-causing chemical in Zantac and related generic drugs to treat ulcers and reflux disease. The same chemical has been linked to dozens of recalls of prescription blood pressure drugs in the past year.

The drugstore chains CVS Health , Walgreens and Rite Aid have already pulled Zantac products from their shelves.


Explore further

CVS stops sale of heartburn drugs with suspect contaminant

© 2019 The Associated Press. All rights reserved.

Citation: Retail giant Walmart halts sales of Zantac and related drugs (2019, October 2) retrieved 31 March 2020 from https://medicalxpress.com/news/2019-10-retail-giant-walmart-halts-sales.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments